Salt CompositionYou Searched
Mofecon OS Oral Suspension
Concord Biotech Ltd.
₹9,720
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Prevention of organ rejection in transplant patients
Customers also bought
More About Mofecon
Benefits
In Prevention of organ rejection in transplant patients : Mofecon OS Oral Suspension belongs to a group of medicines known as immunosuppressive agents. It lowers your immune response and reduces the chance of your body attacking the transplanted organ. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine may be used in combination with other medicines to suppress the immune system and help your body accept the new organ.
Side Effects
Side effects of Mofecon Oral Suspension The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Mofecon Nausea Vomiting Diarrhea Abdominal pain Headache High blood pressure Decreased white blood cell count (neutrophils)Fungal infection Low blood platelets Anemia (low number of red blood cells)Skin cancer Bacterial infection Hypercholesterolemia (high cholesterol)Viral infection Electrolyte imbalance Gout
How to use
How to use Mofecon Oral Suspension Follow your doctor's guidance regarding the dose and duration of this medication. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Mofecon OS Oral Suspension is to be taken with food.
How it works
How Mofecon Oral Suspension works Mofecon OS Oral Suspension is an immunosuppressant. It reduces the action of the body's own defense system (the immune system) and prevents rejection of the transplanted organ.
Safe: No harmful side effects are associated with consuming alcohol alongside Mofecon OS Oral Suspension
Mofecon OS Oral Suspension is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Mofecon OS Oral Suspension is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Mofecon OS Oral Suspension does not usually affect your ability to drive.
Mofecon OS Oral Suspension should be used with caution in patients with severe kidney disease. Dose adjustment of Mofecon OS Oral Suspension may be needed. Doctor consultation is advised.
There is limited information available on the use of Mofecon OS Oral Suspension in patients with liver disease. Doctor consultation is advised.
Manufacturer Address
403, Iscon Elegance, Nr. Prahalad Nagar Cross Road, Opp. S.G.Highway, Ahmedabad-380015, Gujarat- INDIA.
References
Krensky AM, Bennett WM, Vincenti F. Immunosuppressants, Tolerogens, and Immunostimulants. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1014-15
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 973
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 943-45
Mycophenolate mofetil. South San Francisco, California: Genentech USA, Inc.; 1995 (17 Jun. 2019)
Mycophenolate mofetil. Grenzach-Wyhlen, Germany: Roche Pharma AG; 2018 (17 Jun. 2019)
Central Drugs Standard Control Organisation. Mycophenolate mofetil (25 Jul. 2023)
Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation. 1993 Jul;56(1):75-82 (01 Aug. 2023)
Mycophenolate mofetil. Basel, Switzerland: F. Hoffmann-La Roche Ltd.; 2021 (25 Jul. 2023)
Cell Cept. Mycophenolate mofetil (25 Jul. 2023)
Mycophenolate mofetil (25 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.